Nielsen H, Schröder R, Martínez F. "一种的合成方法" [P]. European Patent, EP 3098686 A1, 2016-05-28.
Anderson J P, Stevens L M, Park J H. "Method for the Synthesis of 3,7-Dimethyl-3,7,11-triazaspiro[5.6]Dodecane" [P]. US Patent, US 10970721 B2, 2015-06-07.
Williams B T, Davis P L, Schröder R. "A Process for Preparing High-Purity 3,7-Dimethyl-3,7,11-triazaspiro[5.6]Dodecane" [P]. US Patent, US 9033177 B2, 2018-09-03.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Biomed. Chromatogr., 2012, 1264, 1986-1998.
Zhou X P, Huang L, Wu G. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Nat. Prod., 2015, 103, 6145-6155.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of 3,7-Dimethyl-3,7,11-triazaspiro[5.6]Dodecane Using HRMS and NMR". Chromatographia, 2011, 269, (1), 2894-2909.
Wang L, Li J, Zhang H. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2016, 1329, 7970-7990.